VOYA Investment Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $578K | Buy |
45,111
+26,993
| +149% | +$344K | ﹤0.01% | 1662 |
|
|
2025
Q4 | $163K | Sell |
18,118
-135,338
| -88% | -$1.86M | ﹤0.01% | 2189 |
|
|
2025
Q3 | $2.65M | Sell |
153,456
-113,605
| -43% | -$1.4M | ﹤0.01% | 1118 |
|
|
2025
Q2 | $2.51M | Buy |
267,061
+59,052
| +28% | +$485K | ﹤0.01% | 1207 |
|
|
2025
Q1 | $1.48M | Buy |
208,009
+179,180
| +622% | +$1.81M | ﹤0.01% | 1422 |
|
|
2024
Q4 | $336K | Sell |
28,829
-2,213
| -7% | -$34.5K | ﹤0.01% | 2145 |
|
|
2024
Q3 | $638K | Sell |
31,042
-866
| -3% | -$20K | ﹤0.01% | 1870 |
|
|
2024
Q2 | $714K | Sell |
31,908
-49,133
| -61% | -$1.17M | ﹤0.01% | 1811 |
|
|
2024
Q1 | $2.23M | Sell |
81,041
-13,679
| -14% | -$380K | ﹤0.01% | 1314 |
|
|
2023
Q4 | $2.89M | Buy |
94,720
+38,170
| +67% | +$1.1M | ﹤0.01% | 1221 |
|
|
2023
Q3 | $1.79M | Buy |
56,550
+21,703
| +62% | +$842K | ﹤0.01% | 1370 |
|
|
2023
Q2 | $1.42M | Sell |
34,847
-43,270
| -55% | -$1.75M | ﹤0.01% | 1490 |
|
|
2023
Q1 | $2.91M | Sell |
78,117
-37,678
| -33% | -$1.48M | ﹤0.01% | 1201 |
|
|
2022
Q4 | $4.04M | Buy |
115,795
+2,950
| +3% | +$140K | ﹤0.01% | 1050 |
|
|
2022
Q3 | $6.31M | Buy |
112,845
+42,530
| +60% | +$2.64M | 0.01% | 863 |
|
|
2022
Q2 | $3.64M | Sell |
70,315
-114,058
| -62% | -$5.79M | 0.01% | 858 |
|
|
2022
Q1 | $13.4M | Buy |
184,373
+157,452
| +585% | +$13.3M | 0.03% | 504 |
|
|
2021
Q4 | $3.18M | Buy |
26,921
+160
| +0.6% | +$20K | 0.01% | 976 |
|
|
2021
Q3 | $3.59M | Buy |
26,761
+1,662
| +7% | +$252K | 0.01% | 950 |
|
|
2021
Q2 | $4.06M | Buy |
25,099
+1,050
| +4% | +$81.8K | 0.01% | 939 |
|
|
2021
Q1 | $1.93M | Buy |
24,049
+1,998
| +9% | +$134K | ﹤0.01% | 1202 |
|
|
2020
Q4 | $1.2M | Buy |
22,051
+5,482
| +33% | +$199K | ﹤0.01% | 1404 |
|
|
2020
Q3 | $329K | Buy |
16,569
+1,299
| +9% | +$27.1K | ﹤0.01% | 1894 |
|
|
2020
Q2 | $321K | Sell |
15,270
-4,196
| -22% | -$71.3K | ﹤0.01% | 1924 |
|
|
2020
Q1 | $238K | Buy |
19,466
+899
| +5% | +$12.1K | ﹤0.01% | 2030 |
|
|
2019
Q4 | $272K | Buy |
18,567
+3,874
| +26% | +$53.9K | ﹤0.01% | 2225 |
|
|
2019
Q3 | $196K | Hold |
14,693
| – | – | ﹤0.01% | 2251 |
|
|
2019
Q2 | $241K | Buy |
14,693
+366
| +3% | +$5.75K | ﹤0.01% | 2199 |
|
|
2019
Q1 | $245K | Hold |
14,327
| – | – | ﹤0.01% | 2159 |
|
|
2018
Q4 | $196K | Buy |
14,327
+1,518
| +12% | +$28.2K | ﹤0.01% | 2227 |
|
|
2018
Q3 | $367K | Hold |
12,809
| – | – | ﹤0.01% | 2033 |
|
|
2018
Q2 | $350K | Buy |
+12,809
| New | +$310K | ﹤0.01% | 2053 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
